These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 29042865)
1. Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Yang EA; Lee KY Korean J Pediatr; 2017 Aug; 60(8):245-247. PubMed ID: 29042865 [No Abstract] [Full Text] [Related]
2. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Lee H; Yun KW; Lee HJ; Choi EH Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389 [TBL] [Abstract][Full Text] [Related]
3. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534 [TBL] [Abstract][Full Text] [Related]
4. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. Cao B; Qu JX; Yin YD; Eldere JV Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial and immunomodulatory effect of clarithromycin on macrolide-resistant Mycoplasma pneumoniae. Kurata S; Taguchi H; Sasaki T; Fujioka Y; Kamiya S J Med Microbiol; 2010 Jun; 59(Pt 6):693-701. PubMed ID: 20223900 [TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195 [TBL] [Abstract][Full Text] [Related]
7. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children]. Bao F; Qu JX; Liu ZJ; Qin XG; Cao B Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804 [TBL] [Abstract][Full Text] [Related]
8. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report. Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Lightmix Mycoplasma macrolide assay for detection of macrolide-resistant Mycoplasma pneumoniae in pneumonia patients. Wagner K; Imkamp F; Pires VP; Keller PM Clin Microbiol Infect; 2019 Mar; 25(3):383.e5-383.e7. PubMed ID: 30391582 [TBL] [Abstract][Full Text] [Related]
11. Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age. Miyashita N; Maruyama T; Kobayashi T; Kobayashi H; Taguchi O; Kawai Y; Yamaguchi T; Ouchi K; Oka M J Infect Chemother; 2011 Feb; 17(1):114-8. PubMed ID: 20676912 [TBL] [Abstract][Full Text] [Related]
12. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy. Lung DC; Chan YH; Kwong L; Que TL Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical manifestations of macrolide resistant Lee E; Cho HJ; Hong SJ; Lee J; Sung H; Yu J Korean J Pediatr; 2017 May; 60(5):151-157. PubMed ID: 28592978 [TBL] [Abstract][Full Text] [Related]
14. Outbreak of macrolide-resistant mycoplasma pneumoniae in a primary school in Beijing, China in 2018. Zhang WZ; Zhang SJ; Wang QY; Li YD; Jing HB; Hu GY; Wu D BMC Infect Dis; 2019 Oct; 19(1):871. PubMed ID: 31640591 [TBL] [Abstract][Full Text] [Related]
15. Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Yamada M; Buller R; Bledsoe S; Storch GA Pediatr Infect Dis J; 2012 Apr; 31(4):409-0. PubMed ID: 22209916 [TBL] [Abstract][Full Text] [Related]
16. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia. Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263 [TBL] [Abstract][Full Text] [Related]
17. Early Corticosteroid Therapy for Yang EA; Kang HM; Rhim JW; Kang JH; Lee KY J Clin Med; 2019 May; 8(5):. PubMed ID: 31121867 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and genotyping of Zhao F; Liu J; Shi W; Huang F; Liu L; Zhao S; Zhang J Antimicrob Resist Infect Control; 2019; 8():18. PubMed ID: 30697421 [TBL] [Abstract][Full Text] [Related]
19. Macrolide Resistance and Its Impacts on M. Pneumoniae Pneumonia in Children: Comparison of Two Recent Epidemics in Korea. Kim JH; Kim JY; Yoo CH; Seo WH; Yoo Y; Song DJ; Choung JT Allergy Asthma Immunol Res; 2017 Jul; 9(4):340-346. PubMed ID: 28497921 [TBL] [Abstract][Full Text] [Related]
20. No detection of macrolide-resistant Mycoplasma pneumoniae from Swedish patients, 1996-2013. Gullsby K; Bondeson K Infect Ecol Epidemiol; 2016; 6():31374. PubMed ID: 27258207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]